Holen Sie sich die Stockscreener-App
3.46
2.26%
-0.08
Handel nachbörslich:
3.42
-0.04
-1.16%
Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten
What technical models suggest about Perspective Therapeutics Inc.’s comeback2025 Volume Leaders & Daily Price Action Insights - Newser
Is Perspective Therapeutics Inc. stock entering bullish territoryPortfolio Return Summary & Weekly Stock Breakout Alerts - Newser
Chart overlay techniques for tracking Perspective Therapeutics Inc.July 2025 Closing Moves & Fast Gain Stock Trading Tips - Newser
Leading vs lagging indicators on Perspective Therapeutics Inc. performanceJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - Newser
How to use a screener to detect Perspective Therapeutics Inc. breakoutsJuly 2025 Summary & Real-Time Volume Analysis Alerts - Newser
Risk vs reward if holding onto Perspective Therapeutics Inc.Trade Performance Summary & Precise Buy Zone Tips - Newser
Perspective Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Reactions & Momentum Based Trading Ideas - Newser
Can volume confirm reversal in Perspective Therapeutics Inc.2025 Major Catalysts & Pattern Based Trade Signal System - Newser
What indicators show strength in Perspective Therapeutics Inc.2025 EndofYear Setup & Safe Capital Investment Plans - Newser
Applying chart zones and confluence areas to Perspective Therapeutics Inc.July 2025 Analyst Calls & Community Verified Swing Trade Signals - Newser
Perspective Therapeutics Announces Chief Financial Officer Changes - MarketScreener
Perspective Therapeutics Names Joel Sendek as CFO - MarketScreener
Perspective Therapeutics Appoints Joel Sendek as CFO - TipRanks
Perspective Therapeutics' Strategic Leadership Shift: How CFO Joel Sendek Could Ignite Financial and Operational Momentum - AInvest
Perspective Therapeutics' Strategic Leadership Move and Its Implications for Biotech Growth - AInvest
Perspective Therapeutics Appoints Biotech Veteran Joel Sendek as Chief Financial Officer - GlobeNewswire
Former Wall Street All-Star Who Raised $2.5B: Perspective Therapeutics Lands Biotech Finance Veteran as CFO - Stock Titan
Smart tools for monitoring Perspective Therapeutics Inc.’s price actionEntry Point & Long-Term Safe Return Strategies - Newser
Aug EndMonth: Can Perspective Therapeutics Inc. deliver alphaJuly 2025 Trade Ideas & High Accuracy Investment Entry Signals - khodrobank.com
Is Perspective Therapeutics Inc. being accumulated by smart moneyEarnings Miss & Short-Term Swing Trade Alerts - خودرو بانک
Building trade automation scripts for Perspective Therapeutics Inc.2025 Breakouts & Breakdowns & Technical Pattern Based Signals - Newser
Will Perspective Therapeutics Inc. outperform the marketEarnings Performance Report & Free Real-Time Market Sentiment Alerts - Newser
Perspective Therapeutics shares fall 1.02% after-hours following appointment of Maya Martinez-Davis to the Board of Directors. - AInvest
How does Perspective Therapeutics Inc. score in quality rankingsWeekly Stock Summary & AI Enhanced Trading Signals - خودرو بانک
Published on: 2025-09-03 09:07:22 - Newser
What institutional flow reveals about Perspective Therapeutics Inc.July 2025 Selloffs & Low Drawdown Investment Strategies - Newser
Perspective Therapeutics Appoints Maya Martinez-Davis to Board - TipRanks
Analyzing drawdowns of Perspective Therapeutics Inc. with statistical tools2025 Year in Review & Real-Time Stock Entry Alerts - Newser
Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors. - AInvest
Perspective Therapeutics appoints Maya Martinez-Davis as independent director. - AInvest
Perspective Therapeutics Appoints Maya Martinez-Davis to Board, Boosting Oncology Expertise - AInvest
Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors - MarketScreener
GSK US Commercial President Maya Martinez-Davis Joins Perspective Therapeutics' Board of Directors - Stock Titan
Published on: 2025-09-03 04:22:19 - Newser
Custom strategy builders for tracking Perspective Therapeutics Inc.July 2025 Selloffs & Weekly High Return Stock Forecasts - Newser
Analyst Downgrade: How does Perspective Therapeutics Inc. score in quality rankingsWeekly Stock Summary & Free Technical Confirmation Trade Alerts - خودرو بانک
Published on: 2025-09-03 01:26:42 - Newser
ETF Watch: Does Perspective Therapeutics Inc. stock have upside surprise potentialJuly 2025 Technicals & Reliable Price Breakout Alerts - خودرو بانک
Using fundamentals and technicals on Perspective Therapeutics Inc.Quarterly Portfolio Review & Daily Momentum Trading Reports - Newser
Is Perspective Therapeutics Inc. gaining market shareEarnings Risk Report & Daily Profit Focused Stock Screening - خودرو بانک
Perspective Therapeutics Updates on Radiopharmaceutical Advancements - TipRanks
Is a relief rally coming for Perspective Therapeutics Inc. holdersMarket Growth Report & Community Consensus Picks - Newser
Can Perspective Therapeutics Inc. deliver alphaCPI Data & Weekly High Return Forecasts - خودرو بانک
Update Recap: Is Perspective Therapeutics Inc. gaining market share2025 Fundamental Recap & Long-Term Investment Growth Plans - خودرو بانک
Does Perspective Therapeutics Inc. stock reflect fundamentalsWeekly Profit Summary & Daily Growth Stock Tips - خودرو بانک
Perspective Therapeutics Inc. Trading Near Value Zone — Recovery Ahead getLinesFromResByArray error: size == 0 - 강소기업뉴스
Perspective Therapeutics Inc. Volume Confirms Breakout — Analysts Bullish getLinesFromResByArray error: size == 0 - 강소기업뉴스
How institutional ownership impacts Perspective Therapeutics Inc. stockWeekly Investment Summary & Accurate Buy Signal Alerts - Newser
Technical signs of recovery in Perspective Therapeutics Inc.Fed Meeting & Reliable Price Breakout Signals - Newser
0.78%
0.31%
Kapitalisierung:
|
Volumen (24h):